Laury Baillon

Université Claude Bernard Lyon 1 — France

Medicine · Health Sciences

15h-index2.0kcitations31works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(10), Influenza Virus Research Studies(6), Respiratory viral infections research(6), Animal Virus Infections Studies(6), COVID-19 Clinical Research Studies(5)

Publications31 total

Resistance of endothelial cells to SARS-CoV-2 infection <i>in vitro</i>
Journal of Virology·2025Open Access
Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer
Breast Cancer Research·2025Open Access
SARS-CoV-2 variants retain high airborne transmissibility by different strategies
npj Viruses·2025Open Access
Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer
2025· 2 citedOpen Access
Omicron breakthrough infections in vaccinated or previously infected hamsters
Proceedings of the National Academy of Sciences·2023· 10 citedOpen Access
An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization
Nature Communications·2023· 29 citedOpen Access
A Targeted Amino Acid Mutation in Influenza a Virus Universal Epitope Transforms Immunogenicity and Protective Immunity via CD4 T Cell Activation
SSRN Electronic Journal·2023· 1 citedOpen Access
Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19
Nature Communications·2022· 42 citedOpen Access
Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model
Journal of Virology·2022· 29 citedOpen Access
Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1
Mucosal Immunology·2022· 37 citedOpen Access
Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature upon SARS-CoV-2 sensing by monocytes in COVID-19
2022· 6 citedOpen Access
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model
Vaccine·2022· 12 citedOpen Access
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway
Cell Reports·2022· 68 citedOpen Access
A natural variant in ANP32B impairs influenza virus replication in human cells
Journal of General Virology·2021· 13 citedOpen Access
Mutations that adapt SARS-CoV-2 to mustelid hosts do not increase fitness in the human airway.
Research Square (Research Square)·2021· 3 citedOpen Access
Mutations that adapt SARS-CoV-2 to mustelid hosts do not increase fitness in the human airway
2021· 3 citedOpen Access
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
Nature Microbiology·2021· 785 citedOpen Access
Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
2021· 96 cited
Resistance of endothelial cells to SARS-CoV-2 infection <i>in vitro</i>
2020· 34 citedOpen Access
The Viral Hemorrhagic Septicemia Virus (VHSV) Markers of Virulence in Rainbow Trout (Oncorhynchus mykiss)
Frontiers in Microbiology·2020· 45 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

William Barclay(20), Thomas P. Peacock(14), Rebecca Frise(14), Jie Zhou(9), Jonathan C. Brown(9), Daniel H. Goldhill(8), Ruthiran Kugathasan(8), Olivia C. Swann(6), Paul F. McKay(6), Rebecca Penn(5), Ecco Staller(5), Nicole Faury(5), Vanessa M. Cowton(4), Wilhelm Furnon(4), Arvind H. Patel(4), Massimo Palmarini(4), Amélie Segarra(4), Delphine Tourbiez(4), Tristan Renault(4), Ksenia Sukhova(4)